Clinical Trial Update: Varenicline Effects In Schizophrenic Smokers [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated varenicline effects in smokers with schizophrenia, with completed status and results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Schizophrenia
• Tobacco Use Disorder

Drugs mentioned

• Varenicline (varenicline)

Snippet

Sponsor: Nathan Kline Institute for Psychiatric Research | Conditions: Schizophrenia, Tobacco Use Disorder | Phase 4 | Status: COMPLETED | Results posted: 2017-09-05